Actively Recruiting
The Jordan Study for End-Stage Renal Disease Subjects
Led by Alio, Inc. · Updated on 2024-06-21
75
Participants Needed
1
Research Sites
136 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To compare the Alio device to blood draws.
CONDITIONS
Official Title
The Jordan Study for End-Stage Renal Disease Subjects
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age or older
- Receiving maintenance dialysis for End Stage Renal Disease via arteriovenous fistula (AVF) or graft (AVG) in an arm location for at least 6 months
- Able to provide written informed consent
- Able to wear the SmartPatch device as instructed and follow study protocols
You will not qualify if you...
- Skin near the device placement area is swollen, infected, or inflamed
- Pregnancy
- Serious medical condition that may affect safety or device evaluation as judged by the investigator
- AVF or AVG located outside an arm
- Participants with novel AVG types such as HeRO grafts
- Participation in other clinical trials that could affect study data quality
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Jordan Center for Pharmaceutical Research
Amman, Jordan, 11195
Actively Recruiting
Research Team
E
Emilee Scates
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here